The University of San Francisco

USF Scholarship: a digital repository @ Gleeson Library | Geschke
Center
Doctor of Nursing Practice (DNP) Projects

Theses, Dissertations, Capstones and Projects

Spring 5-20-2022

Psychosocial Distress Screening for Patients with Cancer: A
Value-Based Approach to the Integration and Delivery of Holistic
Care
Candy Cheung
University of San Francisco, ccheung3@usfca.edu

Follow this and additional works at: https://repository.usfca.edu/dnp
Part of the Nursing Commons

Recommended Citation
Cheung, Candy, "Psychosocial Distress Screening for Patients with Cancer: A Value-Based Approach to
the Integration and Delivery of Holistic Care" (2022). Doctor of Nursing Practice (DNP) Projects. 290.
https://repository.usfca.edu/dnp/290

This Project is brought to you for free and open access by the Theses, Dissertations, Capstones and Projects at
USF Scholarship: a digital repository @ Gleeson Library | Geschke Center. It has been accepted for inclusion in
Doctor of Nursing Practice (DNP) Projects by an authorized administrator of USF Scholarship: a digital repository @
Gleeson Library | Geschke Center. For more information, please contact repository@usfca.edu.

1

Title
Psychosocial Distress Screening for Patients with Cancer:
A Value-Based Approach to the Integration and Delivery of Holistic Care

Candy Cheung. BSN, RN
School of Nursing and Health Professions, University of San Francisco
DNP Chair: Dr. Prabjot Sandhu
DNP Committee Member: Dr. Victoria Chaudhary
DNP Project Mentor: Lisa McNey

2
TABLE OF CONTENTS

SECTION I: TITLE AND ABSTRACT
TITLE ...................................................................................................................................... 1
ABSTRACT .............................................................................................................................. 4
SECTION II: INTRODUCTION
BACKGROUND ........................................................................................................................ 6
PROBLEM DESCRIPTION ............................................................................................................ 7
LOCAL PROBLEM AND SETTING ................................................................................................... 7
PROJECT AIM.......................................................................................................................... 8
AVAILABLE KNOWLEDGE ........................................................................................................ 8
PICOT QUESTION ................................................................................................................... 8
SEARCH METHODOLOGY ........................................................................................................... 8
REVIEW OF THE LITERATURE ...................................................................................................... 9
SUMMARY OF THE EVIDENCE ................................................................................................... 10
RATIONALE............................................................................................................................11
ETHICAL AND POLICY CONSIDERATIONS ................................................................................11
SECTION III: METHODS
IMPLEMENTATION/INTERVENTION .......................................................................................12
DESCRIPTION OF THE INTERVENTIONS ........................................................................................ 12
GAP ANALYSIS ...................................................................................................................... 14
GANTT CHART ...................................................................................................................... 14
SWOT ANALYSIS .................................................................................................................. 14
WORK BREAKDOWN STRUCTURE .............................................................................................. 15
BUDGET AND FINANCIAL ANALYSIS ............................................................................................ 15
RETURN ON INVESTMENT ........................................................................................................ 16
RESPONSIBILITY AND COMMUNICATION MATRIX .......................................................................... 16
OUTCOME MEASURES ...........................................................................................................16
CQI METHOD, DATA COLLECTION TOOLS & ANALYSIS .................................................................. 17
SECTION IV: RESULTS
RESULTS ................................................................................................................................17
CONCLUSION .........................................................................................................................19
LIMITATIONS ........................................................................................................................ 20

3
IMPLICATIONS FOR PRACTICE ................................................................................................... 20
FUNDING ...............................................................................................................................21
REFERENCES ..........................................................................................................................22
APPENDICES ..........................................................................................................................27
APPENDIX A: EVIDENCE TABLE ................................................................................................. 27
APPENDIX B: BIOPSYCHOSOCIAL MODEL .................................................................................... 53
APPENDIX C: STATEMENT OF DETERMINATION ............................................................................ 54
APPENDIX D: LETTER OF SUPPORT ............................................................................................ 58
APPENDIX E: NCCN DISTRESS THERMOMETER ............................................................................ 59
APPENDIX F: PATIENT QUESTIONNAIRE ...................................................................................... 60
APPENDIX G: PATIENT PAMPHLET............................................................................................. 64
APPENDIX H: NP EDUCATION .................................................................................................. 66
APPENDIX I: NP PRE-INTERVENTION SURVEY .............................................................................. 69
APPENDIX J: NP POST-INTERVENTION SURVEY ............................................................................ 73
APPENDIX K: GAP ANALYSIS .................................................................................................... 76
APPENDIX L: GANTT CHART ..................................................................................................... 77
APPENDIX M: SWOT ANALYSIS ............................................................................................... 78
APPENDIX N: WORK BREAKDOWN STRUCTURE (TABLE FORMAT) .................................................... 79
APPENDIX O: WORK BREAKDOWN STRUCTURE (HIERARCHY FORMAT) ............................................. 80
APPENDIX P: PROPOSED BUDGET ............................................................................................. 81
APPENDIX Q: COMMUNICATION MATRIX ................................................................................... 82
APPENDIX R: PRE-INTERVENTION NP RESULTS ............................................................................ 83
APPENDIX S: POST-INTERVENTION NP RESULTS .......................................................................... 85
APPENDIX T: PATIENT RESULTS ................................................................................................ 87

4
Abstract
Background: Patients with cancer (PWC) have a high prevalence of experiencing psychosocial
distress as they bear the burden of the disease. Emphasis is needed on psychosocial care, as the
COVID-19 pandemic negatively impacts mental health. Psychosocial distress screening is
considered a standard practice by the National Comprehensive Cancer Network (NCCN), which
recommends using the validated Distress Thermometer (DT) as a screening tool.
Local Problem: The DNP project ambulatory infusion clinic (AIC) site does not have a
standardized distress screening tool for staff. There was a lack of awareness of an existing nonvalidated distress screening and little to no intervention or process for addressing distress in
cancer patients.
Methods: Nurse Practitioners (NPs) were given a pre-intervention survey to assess their
knowledge of distress screening and later received an educational module on the importance of
screening. They were given a post-intervention survey to assess their frequency of distress
screening, knowledge, acceptability, and efficacy of the DT. The DT questionnaire was
distributed to hematology patients to assess distress levels and referral needs.
Interventions: The implementation of the DT screening across all hematology patients at the
ambulatory infusion clinic. NPs received a DT educational training module and patients were
provided a pamphlet with psychosocial resources or referred appropriately.
Results: Distress screening by NPs increased from 50% to 60%. The DT had low efficacy and
acceptability by NPs. None of the patients that met the cutoff score ≥4 received referrals.
Reasons included (a) they already have resources or support, (b) they did not perceive their
distress to be severe enough for interventions, or (c) mental health stigma. All the screened
patients were offered an educational pamphlet on distress with resources. Two patients suggested
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including more COVID questions due to the impact of the pandemic on their distress. Another
questioned the accuracy of the screening because the DT only assesses the patient’s level of
distress experienced in the past week rather than an extended time.
Conclusions: Screening PWC for psychosocial distress is vital for delivering thorough care, and
opportunities to optimize screening and mitigate psychosocial distress are readily available. One
of the core challenges is having institutions adopt a standardized screening tool.
Recommendations for institutions to improve distress screening consist of (a) selecting a
standardized screening tool, (b) incorporating the tool in the electronic health record to improve
clinician workflow, and (c) ongoing education and training on distress screening for new and
current clinicians.
Keywords: Psychosocial distress, cancer care, distress, oncology, psycho-oncology,
psychosocial screening, psychosocial support
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Background
Cancer care and research have advanced over the years, but psychosocial distress
experienced during the cancer care trajectory is often overlooked, contributing to adverse health
outcomes (Adler & Page, 2008). The diagnosis and treatment for patients with cancer (PWC) can
come with the sequelae of ailments affecting the patient physiologically, psychologically,
financially, and socially. Cancer-related distress may precipitate psychosocial costs that can
negatively impact one's quality of life (Essue et al., 2020). Evidence from the literature sheds
light on the importance of incorporating screening for distress, and it should be highly
considered the sixth vital sign among PWC (Howell & Olsen, 2011).
The National Comprehensive Cancer Network [NCCN] (2021) defines distress as an
unpleasant condition that encompasses mental, physical, social, or spiritual factors that influence
how one may cope with cancer. It is reported that approximately 46% of PWC are challenged
with a remarkable level of distress (Carlson et al., 2019). Undetected and untreated psychosocial
distress can further lead to detrimental health consequences, including poor management of
illness and recovery, delay in treatment, decreased treatment adherence, increased healthcare
expenditure, and, ultimately, increased morbidity and mortality (Y. Wang et al., 2020).
The Institute of Medicine (IOM) stated that health is not solely based on biological
factors but psychosocial factors as well, emphasizing the need for a holistic approach in cancer
care. As a result, the IOM released a report in 2008, Cancer Care for the Whole Patient, to raise
more awareness of the psychosocial health of PWC as they make up a growing population of
people living with chronic illnesses in the United States (Adler & Page, 2008). Given the
increased risk of distress experienced by PWC, the National Comprehensive Cancer Network
(NCCN) developed a detailed guideline recommending routine distress screening to promote the
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integration of psychosocial care in cancer management (Andersen et al., 2014). Additionally, the
American College of Surgeons Commission on Cancer [ACSCoC] (2020) published
accreditation standards (Standard 5.2), requiring routine screening and monitoring of PWC for
psychosocial distress while offering referrals for psychosocial interventions if deemed necessary.
Problem Description
Distress screening tools remain underutilized despite various well-validated and reliable
instruments available to cancer centers and the treatment team. Although cancer-related distress
is frequently recognized as a persistent concern in the growing body of literature and mandatory
guidelines have long been established since 2015, screening rates are suboptimal due to
numerous barriers encountered by clinicians and patients. Improvements to psychosocial
screening are imperative to identify PWC for distress and allocate the necessary resources to
enhance psychosocial care (Carlson et al., 2019).
The emergence of the coronavirus disease 2019 (COVID-19) has profoundly shifted the
way providers deliver care to cancer patients, as the population faces lockdown measures, social
isolation, uncertainty, and disruption in receiving cancer care (WHO, 2020). The psychological
impact of the COVID-19 pandemic adds an emotional burden as people are suffering more
stress, anxiety, and depression worldwide (C. Wang et al., 2020). Considering the population's
high susceptibility, COVID-19 can produce an increased risk of psychosocial distress among
PWC.
Local Problem and Setting
The DNP project was implemented in the ambulatory infusion clinic (AIC) in an
academic medical center in the San Francisco Bay Area that provides care for adult hematology
patients. The stakeholders include two clinic nurse managers, registered nurses, NPs,
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oncologists, social workers, psycho-oncologists, and patients and their caregivers. The facility
did not have a standardized distress screening tool for staff, which is an issue given that PWC are
susceptible to experiencing distress. There was also a lack of awareness of available distress
screening tools contributing to inconsistency in patient care and missed opportunities for
detecting patients with distress. Therefore, clinicians and the administration were willing to
approve and support the quality improvement project to improve psychosocial care (Appendix
D).
Project Aim
This project aim was to develop, implement, and evaluate a psychosocial distress
screening program at the AIC to increase NP-administered distress screening by 25% three
months post-intervention. Another goal of the DNP project includes increasing clinician
knowledge of practice guidelines and social work and psycho-oncological services to 100% so
that PWC can receive appropriate psychosocial care. The overall goal is to improve cancer care,
reduce the risk of adverse health outcomes, and enhance the patient experience during treatment.
Available Knowledge
PICOT Question
In a population of hematology patients challenged by COVID-19 in the AIC (P), would
incorporating a psychosocial distress screening program (I) compared with current practices (C)
improve NP knowledge and increase distress screening (O) in a time frame of three months?
Search Methodology
A comprehensive literature search was completed using the following databases:
CINAHL, Scopus, PubMed, and the Cochrane Library of Systematic Reviews to identify
research on psychosocial distress screening in PWC. Keywords and free-text terms transcribed
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into the previously mentioned databases included barriers, cancer, cancer
care, distress, oncology, psycho-oncology, psychosocial, psychosocial distress, psychosocial
screening, and psychosocial support. The initial search of the databases yielded a total of 314
articles, of which 12 were selected for review. The evidence was evaluated for strength and
quality using the Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal
Tool (Newhouse et al., 2007). The articles reviewed ranged from level I B to level V B
(Appendix A).
Review of the Literature
Psychological Impact of COVID-19 Pandemic
Romito et al. (2020) and Y. Wang et al. (2020) investigated mental health problems
among PWC during the COVID-19 pandemic. Y. Wang et al. (2020) conducted a cross-sectional
cohort study and reported that patients' concerns about the inconveniences of receiving treatment
were associated with a higher risk of depression. Furthermore, there was a significant
relationship between female patients and increased frequency of worrying about disease
management because of COVID-19; increased psychological pressure due to COVID-19; and
lower sleep quality (Y. Wang et al., 2020). Similarly, Romito et al. (2020) found that female
patients had significantly higher anxiety levels than male patients in their mixed-method cohort
study. Both studies screened patients for COVID-19 related stress factors and mental health
outcomes (Y. Wang et al., 2020; Romito et al., 2020). The two studies found a high prevalence
of mental health issues, raising awareness on the importance of mental health screening during
the pandemic. Despite this, many patients did not seek psychological support, and neither study
reported the reasoning (Y. Wang et al., 2020; Romito et al., 2020).
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Benefits of Psychosocial Distress Screening
The benefits of psychosocial distress screening were also addressed, highlighting its
positive impact on PWC, providers, and the healthcare system. An accessible screening tool
facilitates conversations between the provider and patient while allowing patients to engage and
express their concerns (Groff et al., 2018). Furthermore, providers have reported that a
standardized distress screening tool improved multidisciplinary team collaboration and
documentation (Groff et al., 2018). More importantly, routine screening for distress will help
triage PWC and connect them to the appropriate resources they need through provider referrals.
Early distress detection can prevent long-term psychosocial problems and significantly decrease
psychiatric morbidity, resulting in decreased mental healthcare costs (Riba et al., 2019).
Moreover, distress screening can improve patient satisfaction, adherence to treatment, and
experience during their cancer journey to enhance their overall quality of life (Zebrack et al.,
2015).
Summary of the Evidence
The results from the literature shed light on the importance of distress screening among
cancer patients during the pandemic. Findings revealing the high prevalence of mental health
problems and psychosocial distress are expected as the population is being compounded by the
pandemic (Y. Wang et al., 2020; Romito et al., 2020). Regarding the evidence, there is enough
strength to recommend a change in clinical practice, given the majority of level II and III
evidence included in the review. Based on the studies, healthcare environments have a
significant opportunity to improve health outcomes and provide holistic care for PWC.
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Rationale
The theoretical framework chosen for the project is the Biopsychosocial Model
developed by psychiatrist and internist Engel (1977). The traditional biomedical approach was
believed to be engrossed in pathophysiology, and Engel (1977) wanted a more holistic approach
to promote patient-centered care. As a result, the Biopsychosocial Model is a multidisciplinary
standpoint that focuses systematically on the relationship between the three concepts: biological
(genetics), psychological (mood, personality, behavior), and social factors (familial,
socioeconomic, cultural, education) in the patients' health and well-being as depicted in
Appendix B (Perspectives Clinic, n.d.). The model helped address the project’s AIM statement to
understand the phenomena of hematology patients' psychosocial distress by viewing them as a
whole person and assessing their biological, psychological, and social factors. The three concepts
of the model can influence the manifestation of a disease, health treatment, and the patient's
outcome.
The framework helped explain the phenomenon of interest, as it addressed the biological,
psychological, and social factors among PWC coping with the pandemic. Furthermore, the
Biopsychosocial Model application to the project facilitates the promotion of quality patient care
by addressing psychosocial needs, enhancing the professional role of nurse practitioners, and
improving health outcomes among hematology patients.
Ethical and Policy Considerations
One of the core Jesuit values that resonate with this DNP project and relate to the
Biopsychosocial Model is Curas Personalis, which means caring for the entire person – mind,
body, and spirit (University of San Francisco, 2021). It is vital to address not just the biological
aspects of the hematology patients but to provide care for them as a whole by considering their
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psychosocial needs. The American Nurses Association (ANA) Code of Ethics principles
embodied by this project includes Provision 2.3, stating the importance of collaborating with
other health professionals to ensure high-quality patient care. The DNP project interventions
require collaboration with the multidisciplinary team to improve workflow and utilize existing
resources. Provision 3 states, "The nurse promotes, advocates for, and protects the right, health,
and safety of the patient." This provision will be integrated throughout the project by protecting
the patients' privacy and ensuring confidentiality. Another principle related to this project is
Provision 7.2, "Contributions through developing, maintaining, and implementing professional
practice standards." This quality improvement project adheres to the IOM, NCCN, ACSCoC
guidelines and recommendations of best practices for distress screening for cancer patients. The
DNP chair and committee reviewed the DNP project and Statement of Determination (Appendix
C) and determined that this quality improvement project was non-research. Therefore, an
Institutional Review Board (IRB) approval was not required.
Implementation/Intervention
Description of the Interventions
Distress Thermometer and Questionnaire for Patients
The Distress Thermometer (DT) is a validated, self-reported tool based on evidence from
the literature, and it is recommended by the NCCN (Appendix D). The instrument is available in
over 50 languages and allows patients to rate their level of distress on a scale of 0 (no distress) to
10 (extreme distress). A problem list is also included for patients to check off boxes on possible
stressors potentially contributing to their distress. The list includes: (a) practical problems, (b)
family problems, (c) emotional problems, (d) spiritual/religious problems, (e) physical problems
(NCCN Distress Thermometer for Patients, 2013). The DNP student developed a separate
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questionnaire to collect patient demographic information (Appendix E). The original plan was to
educate the medical assistants to distribute the questionnaire. However, the DNP student
administered the questionnaires (paper format) to patients after check-in due to time constraints.
The patients had enough time to complete the surveys while actively receiving treatments. An
interpreter on an electronic tablet was used to include patients that spoke another language other
than English. Based on the DT results, the DNP student checked off the appropriate boxes on the
top left corner indicating the interventions that were made for the patient during that time, such
as (a) Not needed, (b) Social work referral, (c) Psycho-oncology referral, (d) Patient declined,
and (f) Other (indicate reasoning). The DNP student brought attention to patients that met the
cutoff score (≥ 4) for distress to the NPs for appropriate follow-up. Patient identifiers on the
surveys were then removed to ensure confidentiality.
Patient Pamphlet
All patients were offered a pamphlet with education on distress and resources available
online and at the AIC (Appendix F).
Distress Screening Education for NPs
NPs were educated on the importance of distress screening and utilization of the DT on a
virtual platform via a 15-minute PowerPoint during an NP staff meeting (Appendix G).
Pre-and-Post Intervention Survey for NPs
NPs completed a pre-and-post intervention survey on Qualtrics (Appendix H & I). The
pre-intervention survey was distributed before the PowerPoint education module to assess their
knowledge and compliance with distress screening. The post-intervention survey evaluated their
knowledge, compliance, and acceptability of the DT at the end of the project.
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Gap Analysis
The gap identified from the literature was that the main barriers to distress screening
included inadequate staff, lack of time or competing demands, and staff turnover (Knies et al.,
2019). Other factors include resistance to change, lack of training or awareness of available
distress screening tools, provider knowledge and skills when conducting screenings, providerpatient rapport, absence of psycho-oncological referral services, and collaboration between
stakeholders (Ehlers et al., 2019). (See Appendix J).
Gantt Chart
The DNP project consisted of four phases depicted in the Gantt chart (See Appendix K).
In the first phase, the DNP student completed a needs assessment to identify available distress
screening tools and current practice guidelines at the AIC, where the project was approved. In
the second phase, a distress screening tool for patients and surveys for clinicians were finalized.
In the third phase, a team kickoff meeting was held with stakeholders to provide education and
training on distress screening. Surveys were also collected from NPs and patients. Project
interventions concluded in the fourth phase.
SWOT Analysis
A SWOT analysis was used to identify and assess the project's strengths, weaknesses,
opportunities, and threats while examining internal and external factors (See Appendix L).
Strengths
The project's strengths included implementation at an academic medical center in a
specialized hematology clinic with trained, experienced clinicians. Leadership from the
hematology clinic was supportive of the project, and the clinic offered a wide availability of
clinical resources and a collaborative interdisciplinary team.
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Weaknesses
There was a lack of knowledge among clinicians regarding current recommendations for
distress screening among cancer patients. Additional weaknesses include a lack of protocol
regarding distress screening at the organization and resistance to change by staff members.
Opportunities
The NCCN developed a guideline recommending routine screening for distress among
patients with cancer, given the prevalence of distress experienced by the population (Andersen et
al., 2014). The project could assist in standardizing distress screening training in the organization
and utilizing psycho-oncological or social work services.
Threats
The project's threats include potential changes in the local, national, or global guidelines
in distress screening.
Work Breakdown Structure
The work breakdown structure (WBS) provides a visual of the project organized in
different levels to identify all the activities needed to execute the project effectively by the
project team (see Appendix M & N). The deliverables comprised meeting with the organization,
completing a gap analysis, developing educational material for clinicians on distress screening,
collecting pre-and-post intervention surveys from clinicians, and collecting questionnaires from
hematology patients.
Budget and Financial Analysis
The budget for the project was primarily for printing expenses which were calculated to
be about $380. There will be no expenses for clinicians' education and training as the session will
occur during a scheduled staff meeting. Non-monetary benefits include compliance with
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ACSCoC accreditation standards, early detection, and interventions for patients experiencing a
significant level of distress that may decrease unmeasurable healthcare costs and increase
clinician knowledge and skills in distress screening (See Appendix O).
Return on Investment
The return on investment (ROI) was challenging to measure for this QI project. However,
educating patients and clinicians on distress increases awareness of available resources, which
can improve patient outcomes, increase patient satisfaction, and decrease complications of
psychosocial distress. Quality care may not be directly measured but provides benefits to the
healthcare system and the patient.
Responsibility and Communication Matrix
At the start of the project, the DNP project team, project sponsors, and stakeholders were
invited to a kickoff meeting on Zoom to introduce the project, objectives, goals, and deliverables.
The project team had monthly Zoom meetings to review the project's status. The project sponsor
and stakeholders received monthly emails about project updates. Project managers, project
sponsors, and stakeholders met monthly via Zoom to update project status and were allowed to
provide feedback. The project manager, project sponsor, project team, and stakeholders
communicated via email to provide feedback by completing a post-intervention survey at the end
of the project. The DNP student worked closely and communicated with clinicians and clinic
managers throughout the project to manage risk or threats to ensure the efficiency of the
proposed plan. (See Appendix P).
Outcome Measures
•

NP knowledge, attitude and beliefs towards distress screening will improve by at least
50%
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•

Increase NP distress screening by 25% (Likert scale questions from pre-and-post
intervention survey)

•

Increase referral rate to 100% for at-risk patients (Number of referrals out of the number
of patients that meet the cutoff score)

CQI Method, Data Collection Tools & Analysis
A pre-and-post intervention survey on Qualtrics (Appendix I & J) for NPs was distributed
through email or QR code to assess their knowledge, attitude, and beliefs toward the distress
screening. The survey included Likert-scale questions that were not validated due to time
constraints. Patients were given the DT questionnaire (paper format) since not all patients could
complete the survey electronically. Patient responses were then collected and transcribed to
Qualtrics for analysis.
Results
Pre-Intervention NP Surveys
Six NP participants responded to the pre-intervention survey, and five NP participants
that completed the pre-intervention survey responded to the post-intervention survey. In the preintervention survey, 66.67% and 50% of NPs stated they knew the NCCN and ACSCoC
guidelines to screen PWC for distress, respectively. Fifty percent of the NPs who took the preintervention survey responded that they screen for distress 'most of the time' compared to 60%
post-intervention. When asked if it is essential to screen patients for distress, 83.33% answered
'strongly agree.' 100% of the NPs 'strongly agree' that the COVID-19 pandemic has had a
negative impact on hematology patients. In the pre-intervention survey, only 33.33% of NPs
were aware of a non-validated psychosocial screening tool that was already in place in the
electronic medical record. 100% of NPs 'strongly agree' that it is important to have a distress
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screening tool accessible to patients, and 100% were also aware of psycho-oncological and social
work services available for patients. When asked how often they made psycho-oncological
referrals, 40% of the NPs answered, 'most of the time.' Furthermore, 33.3% stated they 'always'
reach out to social work for assistance (See Appendix R).
Post-Intervention NP Surveys
In the post-intervention survey, 40% of NPs 'strongly agree' the DT was an effective tool,
80% 'neither agree nor disagree' they were able to identify more patients with distress using the
DT, and 80% 'neither agree nor disagree' they made more referrals to psycho-oncology by using
the DT. When asked how often psycho-oncology referrals were made for at-risk patients during
the implementation of the project, only 20% stated 'always.' Furthermore, only 20% of NPs
answered 'strongly agree' that they will continue to use the DT. 80% of NPs 'neither agree nor
disagree' that the DT impeded their workflow, and 40% 'strongly agree' that the DT was easy to
use. One of the NPs reported that they did not use the DT (See Appendix S.)
Patient Questionnaire
Fifty-six (n=56) hematology patients completed the questionnaire, and the mean DT
score was 3.0, which indicates mild levels of distress. Of the 15 patients that met the cutoff score
>4, 12 declined interventions, and three stated they already had resources. The most frequently
reported emotional problem was 'worry' (41.1%); the physical problem was 'fatigue' (51.8%); the
practical problem was 'treatment decisions' (17.9%); and the family problem was 'dealing with
children' (8.9%) (See Appendix T).
Qualitative Responses
Two patients reported that the questionnaire should include more questions relating to the
COVID-19 pandemic because it contributed to their distress level. Patients that met the cutoff
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score >4 were not referred or did not require interventions for the following reasons: (a) they
already have resources (e.g., psychiatrist, psychologist), (b) were already referred to social work
or psycho-oncology, (c) did not believe their distress severe enough to seek interventions, (d)
mental health stigma, and (e) they already have support at home. Dilworth et al. (2014) also
reported similar findings regarding mental health stigma as their patients voiced negative
perceptions and stigma toward psychosocial care. Two visibly distressed patients declined the
survey, but the DNP student notified the appropriate NP to follow up. All patients were offered
an educational pamphlet with resources regardless of their DT score.
Conclusion
Although distress level scores were low and no referrals were made during the project's
timeframe, distress screening remains an essential part of cancer care. The rate of distress
screening by NPs only increased by 10%, instead of the projected target of 25%. The reason is
likely due to a change of the interventions by having the DNP student administer the screening
tool instead of the NPs. Despite the outcome, the NP education and training component of the
intervention contributed to increased awareness of the importance of distress screening. Overall,
PWC are among those who experience a greater risk of psychosocial distress, given the various
challenges with their diagnosis (Y. Wang et al., 2020). It is integral to screen and monitor PWC
for psychosocial distress to ensure that they are provided with appropriate psychosocial care to
address their needs and preserve their mental health and quality of life. It is paramount to provide
PWC access to prevent adverse health outcomes that may contribute to worsening morbidity and
mortality. Recommendations for institutions to improve distress screening include adopting a
standardized distress screening tool, incorporating the tool in the electronic health record to
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improve clinician workflow, and developing education and training on distress for new and
current clinicians.
Limitations
Despite the DT being a validated tool, some limitations include its instructions for the
patient to rate their level of distress based on how they feel in the past week. A patient provided
feedback that the tool only captures their level of distress in a moment in time. Moreover, the
DNP project is not sustainable since the initial intervention plan changed. The DNP student was
the designated person to carry out all the interventions, which may have reflected the low
acceptability and efficacy of the DT by NPs. The psycho-oncology team provided feedback on
incorporating a modified DT in the patient's electronic medical record for improved
documentation accessible to the multidisciplinary team, which is a consideration for future
studies.
Implications for Practice
Screening PWC for distress and improving their access to psychosocial care is crucial to
reducing the psychosocial burden. PWC has a high prevalence of distress, and NPs must consider
taking a holistic approach to health care rather than solely focusing on the disease. Without a
doubt, NPs have the potential to be part of a multidisciplinary team caring for PWC. Education
and training for NPs will help improve uptake of distress screening, remove existing barriers and
stigma to psychosocial care for PWC, and mitigate psychosocial distress (Riba et al., 2019;
Zebrack et al., 2015). Altogether, improvements in current clinical practices are needed to be
congruent with the most recent NCCN and ACSCoC standards of care for distress management
to promote psychosocial care, especially in the setting of an ongoing global pandemic.

21
Funding
The DNP student did not receive funding for this project, and there are no competing
conflicts of interest to disclose.

22

References
Adler, N. E., & Page, A. E. K. (2008). Cancer care for the whole patient: Meeting psychosocial
health needs. The National Academies Press.
American College of Surgeons Commission on Cancer. (2020). Optimal resources for cancer
care: 2020 standards. Retrieved from
https://www.facs.org/-/media/files/qualityprograms/cancer/coc/optimal_resources_for_cancer_care_2020_standards.ashx
American Nurses Association. (2015). Code of ethics with interpretative statements. Silver
Spring, MD: Author. Retrieved from
http://www.nursingworld.org/MainMenuCategories/EthicsStandards/CodeofEthicsforNur
ses/Code-ofEthics-For-Nurses.html
Andersen, B. L., DeRubeis, R. J., Berman, B. S., Gruman, J., Champion, V. L., Massie, M. J.,
Holland, J. C., Partridge, A. H., Bak, K., Somerfield, M. R., & Rowland, J. H. (2014).
Screening, assessment, and care of anxiety and depressive symptoms in adults with
cancer: An American Society of Clinical Oncology guideline adaptation. Journal of
Clinical Oncology, 32(15), 1605-1619. https://doi.org/10.1200/JCO.2013.52.4611
Bodner, S., Patel, A., & Gopalan, P. K. (2019). Improving documentation of distress in veteran
patients for hematology/oncology clinics. Journal of Oncology Practice, 15(5), e475–
e479. https://doi.org/10.1200/JOP.18.00696
Bush, N. J., Goebel, J. R., Hardan-Khalil, K., & Matsumoto, K. (2020). Using a quality
improvement model to implement distress screening in a community cancer setting.

23
Journal of the Advanced Practitioner in Oncology, 11(8), 825–834.
https://doi.org/10.6004/jadpro.2020.11.8.3
Carlson, L. E., Zelinski, E. L., Toivonen, K. I., Sundstrom, L., Jobin, C. T., Damaskos, P., &
Zebrack, B. (2019). Prevalence of psychosocial distress in cancer patients across 55 north
american cancer centers. Journal of Psychosocial Oncology, 37(1), 5-21. doi:
http://dx.doi.org/10.1080/07347332.2018.1521490
Dilworth, S., Higgins, I., Parker, V., Kelly, B., & Turner, J. (2014). Patient and health
professional's perceived barriers to the delivery of psychosocial care to adults with
cancer: a systematic review. Psycho-oncology, 23(6), 601–612.
https://doi.org/10.1002/pon.3474
Ehlers, S. L., Davis, K., Bluethmann, S. M., Quintiliani, L. M., Kendall, J., Ratwani, R. M.,
Diefenbach, M. A., & Graves, K. D. (2019). Screening for psychosocial distress among
patients with cancer: implications for clinical practice, healthcare policy, and
dissemination to enhance cancer survivorship. Translational behavioral medicine, 9(2),
282–291. https://doi.org/10.1093/tbm/iby123
Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science,
196(4286), 129–136. https://doi.org/10.1126/science.847460
Essue, B. M., Iragorri, N., Fitzgerald, N., & de Oliveira, C. (2020). The psychosocial cost burden
of cancer: A systematic literature review. Psycho-Oncology, 29(11), 1746–1760.
https://doi.org/10.1002/pon.5516
Götz, A., Kröner, A., Jenewein, J., & Spirig, R. (2020). Adherence to the distress screening
through oncology nurses and integration of screening results into the nursing process to

24
adapt psychosocial nursing care five years after implementation. European Journal of
Oncology Nursing, 45, https://doi.org/10.1016/j.ejon.2020.101725
Groff, S., Holroyd-Leduc, J., White, D., Bultz, B. D., & Holroyd-Leduc, J. (2018). Examining
the sustainability of screening for distress, the sixth vital sign, in two outpatient oncology
clinics: A mixed-methods study. Psycho-Oncology, 27(1), 141-147.
https://doi.org/10.1002/pon.4388
Howell, D., & Olsen, K. (2011). Distress-the 6th vital sign. Current Oncolog, 18(5), 208–210.
https://doi.org/10.3747/co.v18i5.790
Hui, D., & Bruera, E. (2017). The Edmonton Symptom Assessment System 25 Years Later: Past,
Present, and Future Developments. Journal of pain and symptom management, 53(3),
630–643. https://doi.org/10.1016/j.jpainsymman.2016.10.370
Knies, A. K., Jutagir, D. R., Ercolano, E., Pasacreta, N., Lazenby, M., & McCorkle, R. (2019).
Barriers and facilitators to implementing the commission on cancer's distress screening
program standard. Palliative & Supportive Care, 17(3), 253–261.
https://doi.org/10.1017/S1478951518000378
National Comprehensive Cancer Network. (2021). Distress management. Retrieved from
https://www.nccn.org/professionals/physician_gls/pdf/distress.pdf
Newhouse, R. P., Dearholt, S., Poe, S., Pugh, L. C., & White, K. M. (2007). Organizational
change strategies for evidence-based practice. The Journal of Nursing
Administration, 37(12), 552–557. https://doi.org/10.1097/01.NNA.0000302384.91366.8f
Perspectives Clinic. (n.d.). Biopsychosocial Approach to Understanding Health. Perspectives
Clinic: Clinical & Health Psychology. http://perspectivesclinic.com/health-psychology/

25
Riba, M. B., Donovan, K. A., Andersen, B., Braun, I., Breitbart, W. S., Brewer, B. W.,
Buchmann, L. O., Clark, M. M., Collins, M., Corbett, C., Fleishman, S., Garcia, S.,
Greenberg, D. B., Handzo, R., Hoofring, L., Huang, C. H., Lally, R., Martin, S.,
McGuffey, L., Mitchell, W., … Darlow, S. D. (2019). Distress Management, Version
3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National
Comprehensive Cancer Network: JNCCN, 17(10), 1229–1249.
https://doi.org/10.6004/jnccn.2019.0048
Romito, F., Dellino, M., Loseto, G., Opinto, G., Silvestris, E., Cormio, C., Guarini, A., &
Minoia, C. (2020). Psychological distress in outpatients with lymphoma during the
COVID-19 pandemic. Frontiers in Oncology, 10.
https://doi.org/10.3389/fonc.2020.01270
University of San Francisco. (2021). Our Values. University of San Francisco.
https://www.usfca.edu/about-usf/who-we-are/our-values.
Wang, C., Pan, R., Wan, X., Tan, Y., Xu, L., McIntyre, R. S., Choo, F. N., Tran, B., Ho, R.,
Sharma, V. K., & Ho, C. (2020). A longitudinal study on the mental health of general
population during the COVID-19 epidemic in China. Brain, Behavior, and Immunity, 87,
40-48. https://doi.org/S0889-1591(20)30511-0
Wang, Y., Duan, Z., Ma, Z., Mao, Y., Li, X., Wilson, A., Qin, H., Ou, J., Peng, K., Zhou, F., Li,
C., Liu, Z., & Chen, R. (2020). Epidemiology of mental health problems among patients
with cancer during COVID-19 pandemic. Translational Psychiatry, 10(1), 1-10.
https://doi.org/10.1038/s41398-020-00950-y
World Health Organization. (2020). Coronavirus disease (COVID-19). Retrieved from
https://www.who.int/emergencies/diseases/novel-coronavirus-2019

26
Zebrack, B., Kayser, K., Sundstrom, L., Savas, S. A., Henrickson, C., Acquati, C., & Tamas, R.
L. (2015). Psychosocial distress screening implementation in cancer care: an analysis of
adherence, responsiveness, and acceptability. Journal of Clinical Oncology, 33(10),
1165–1170. https://doi.org/10.1200/JCO.2014.57.4020

27
Appendices
Appendix A: Evidence Table
Citation

Bodner
et al.,
2019

Study
Design/Method

Sample/
Setting

Quality
improvement.
Quantitative,
cohort, crosssectional study to
improve distress
documentation

N=88
hematology/
Oncology
veteran patients

Method:
Plan-Do-StudyAct (PDSA)
cycles
Study was
implemented in 3
cycles

Setting: VA
medical center
in Gainesville,
Florida

Variables
Studied and
Their
Definitions
IV: Veteran
PWC
DV:
Documentation
of distress
screening

Measurement

Data Analysis

-Rates of
distress
documentation

Documentation
rates increased
with each cycle
but was not able
to meet the goal
of 50%

-Percentages of
documented
problems based
on the NCCN
Distress
Thermometer
w/ Problem List

Documentation
rates
1st week: 14%
2nd week: 20.5%
3rd week: 36%

Findings

-Compliance increased
with each cycle due to
provider education,
email reminders,
personal reminders
-Distress screening/
documentation rates
may be low due to
increased workload
-Lack of buy-in by
check-in staff and
physicians

42% of patients
reported distress
level ≥4
Problem List
Most common
were fatigue
(19%), pain
(16%),
neuropathy
(12%), skin
irritation
(11.4%)

IV: Independent variable; DV: Dependent Variable; PWC: Patients with cancer; NCCN: National Comprehensive Cancer Network

Appraisal: Worth to
Practice
Quality of Evidence:
Level V, B
Weaknesses:
-Small sample size
-Single facility
-Unclear instructions
for clinicians and staff
in approaching
patients to complete
screening
-No instruction for
physicians to
document patient
refusal of screening
-Physicians using the
“copy forward”
method in
documentation in
their notes which may
decrease validity of
results
-Interventions not
feasible/transferrable
Strengths:
-Sufficient sample
size
-Use of validated tool
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Citation

Bush et al.,
2020

Study Design/
Method

Quality
improvement
project to
implement
distress
screening
Qualitative,
cross-sectional
design
Method:
Plan-Do-StudyAct model
-Web-based
DSP
2nd outcome:
improve referral
and access to
resources for
PWC

Sample/
Setting

N=21
participants
Setting:
Community
cancer setting

Variables
Studied and
Their
Definitions
IV: CSS

Measurement

Data Analysis

Findings

Demographics

DV: Distress
scores

Means for
distress scores

Mean distress score:
22.14 out of 60 with
severe distress being >40

Staff buy-in was a
barrier to
screening

Quality of
Evidence:
Level V, B

62% (n=13) participants
reported moderate to
severe for one of the
following concerns:
feeling sad/depressed,
feeling nervous/afraid,
feeling lonely/isolated,
feeling too tired to do
things

Recommendations:
systematic tracking
to evaluate
efficacy of
screening and the
ability to address
psychosocial
needs; adequate
referral and
support services to
improve DSP;
adequate training
for staff especially
to be comfortable
with addressing
psychosocial
concerns with
patients

Strengths:
-Validated
instrument

DV2: Endorsed
concerns
DV3:
Depression risk
scores
DV4: Referral
rates

38% of participants were
at risk for clinically
significant depression
and were referred for
therapy
Participants reporting
symptoms attributing to
distress were offered
support to mitigate
symptoms
18 participants perceived
CSS to be helpful

Appraisal:
Worth to
Practice

Weaknesses
-Limited
generalizability
-Small sample
size
-Potential lack
of access to
technology or
limited health
literacy
-Crosssectional
design

Advanced
practitioners play
an important role
in identifying and
mitigating distress

IV: Independent variable; DV: Dependent Variable; PWC: Patients with cancer; PDSA: Plan-Do-Study-Act; CSS: CancerSupportSource; DSP: Distress
Screening Programs
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Citation

Study
Design/Method

Sample/Settin
g

Variables
Studied and
Their
Definitions

Measurement

Data Analysis

Findings

Appraisal: Worth to
Practice

Carlson
et al.,
2018

Quantitative,
cross-sectional
study to:
a) determine the
prevalence of
distress
b) Understand
the correlation
between
demographic
variables, cancer,
type, and distress
c) explore the
importance of
levels of
demographic
variables and
cancer type in
determining
distress

N= 4664 PWC
w/ DT scores

IV: PWC

-Rate of level
of distress

46% of the
participants had
a DT score ≥4

Detecting patients who
are at risk for distress
may help patients get
the appropriate
care/resources they need

Quality of Evidence:
Level II, B

DV: DT
Setting: 55
cancer centers
in the United
States and
Canada from
January to
April 2015

-Demographics
-Cancer
diagnoses

Those who had
a higher
probability of
distress include
females; age 4059; diagnosis of
pancreatic/lung
cancer

Adherence to screening
may not be feasible
Psychoeducational
material may be
distributed to
participants who
screened for mild
distress

Strengths:
-Large sample size
from a diverse
geographical location
-Multicenter study
-Use of validated tool
that is translated into
21 different languages
Weaknesses:
-Cross sectional
design

Online psychosocial
interventions may help
increase outreach

Method: Using
data extracted
from the EMR

IV: Independent variable; DV: Dependent Variable; PWC: Patients with cancer; EMR: Electronic medical record; DT: Distress Thermometer
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Citation

Dilworth et al.,
2014

Study Design/
Method

Sample/
Setting

Qualitative and
quantitative SR

25 articles
reviewed the
results of
barriers to
psychosocial
care among
PWC using the
PRISMA
Guidelines

Variables
Studied and
Their
Definitions
IV: PWC
DV: Barriers

Measurement

Percentage of
each patient
perceived
barriers to
psychosocial
support
Clinician
perceived
barriers
Themes

Data Analysis

Patient perceived
barriers to
psychosocial care:
-No Need/Support
from elsewhere
(38.77%)
-Lack of information
about services
(19.01%)
-Transport/
travel/parking/
location (17/01%)
-No confidence in
services (12.77%)
-Negative perception
and stigma (10.37%)
-Health provider/
communication
(7.89%)
Other barriers
reported at <2%
were: Too busy; too
unwell; and too
expensive.
Qualitative data
reported themes:
cultural,

Findings

Negative opinions
and stigma regarding
psychosocial support
included “feeling
uncomfortable
seeking counselling,”
“negative attitude,”
not wanting psycho
pharmacological
interventions, and not
wanting to join a
group.
-Based on the
qualitative results,
clinician barriers
include lack of
knowledge about
psycho-oncological
services and not
viewing psychosocial
care as part of
standard care. Other
barriers include lack
of awareness of
resources and time
burden
(Most common
barrier).
-Current practice is
not consistent with
psychosocial
standards of care

Appraisal:
Worth to
Practice
Quality of
Evidence:
Level III, B
Strengths:
-Aim is clearly
stated
-Reproducible
search strategy
with multiple
databases and a
flow diagram
-Clearly reported
inclusion and
exclusion criteria
-Table showing
characteristics
from each article
-Consistent
findings
Weaknesses
-Possible risk of
bias in the
screening and
selection process
since only one
researcher
reviewed articles
for relevance
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organizational and
clinician
-Organizational is the
most common theme
(lack of formal
support, lack of
referral to appropriate
services, concerns
about scope of
practice)
-Cultural: lack of
team collaboration,
lack of professional
dialogue, training
marginalizing
psychosocial care;
clinician hesitance
regarding stigma of
psychosocial
interventions

Recommendations:
screening at one point
in time is not
beneficial without
frequently screening
patients and
following up with
them; promoting
psychosocial care for
PWC to decrease
stigma; strategies to
incorporate
psychosocial
screening without the
added workload;
clinician
communication skills
training;
collaborative
strategies

-Clinician: lack of
communication skills
IV: Independent variable; DV: Dependent Variable; SR: Systematic review; PWC: Patients with cancer; PRISMA: Preferred Reporting Items for Systematic
Reviews and Meta-Analyses
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Citation

Study Design/
Method

Sample/
Setting

Götz et
al., 2020

Randomized,
retrospective,
descriptive, pre-,
and postintervention,
cohort study

N=1111
hematology/
oncology
inpatients
(data extracted
from EHR)

Goals:
-Assess nurses’
adherence with
DT screening
-Evaluate
documentation of
distress and
incorporation of
results in the
nursing care plan
-Compare
documentation
and referral rates
before and after
interventions by
reviewing EHR
from the past five
years

Setting:
Cancer center
at University
Hospital
Zurich

Variables
Studied and
Their
Definitions
IV: Screened
patients
IV2:
Unscreened
patients
DV:
Documentation
rate in nursing
care plan
DV2: Support
services rate
postimplementation

Measurement

Data Analysis

Findings

Appraisal: Worth to
Practice

-Nurse
documentation
rates

Psychosocial
issues were
addressed in
nursing care
plans (51.2%)
after
implementation
compared to
24.6% before
implementation

Difficulties in including
psychosocial issues in
care plans may be due
to “sounding
judgmental,” challenges
with developing or
making interventions for
psychosocial problems,
not assessing
psychosocial issues
because emotional
problems are thought to
be common among
PWC

Quality of Evidence:
Level I, B

Nursing documentation
focused more on the
physical problems (pain,
constipation, etc.)

Strengths:
-Large sample size
-Randomized design
-First study to explore
how nurses include
psychosocial concerns
in documentation
(care plans) and
familiarize diagnoses
and interventions
when caring for their
patients

-Pre and post
intervention
referral rates

Referrals
increased to
11.7% from
4.5% after
interventions
Psychosocial
referral rate was
19.9% post
intervention
compared to
4.5% preintervention

-If psychosocial
problems are not
incorporated into the
nursing care plan, the
problems will continue
to be ignored and
inadequately managed
-Being more aware of
psychosocial problems
can improve patientoriented care
-Despite high distress
levels, some patients

Weaknesses:
-One facility
-Retrospective design
-Results cannot be
interpreted causally to
show any correlation
-Results are based on
nursing quality of
documentation
-Results are not
generalizable
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decline psychosocial
services
-The notion of distress
may give people the
impression of a
“psychiatric disorder.”

IV: Independent variable; DV: Dependent Variable; EHR: Electronic Health Record; DT: Distress Thermometer; PWC: Patients with Cancer
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Citation

Groff et
al., 2018

Study Design/
Method

Sample/
Setting

Design:
Mixed-methods,
cross-sectional design
over a 3-week period
in May 2012 to
evaluate the
sustainability of an
SFD program

Sample:
N=163 completed
screening tools (out
of 184 charts
reviewed)

Method:
Sustainability was
assessed 6 months
after implementation
of SFD program
Participants received
screening tools in the
waiting room before
their appointment
Charts were reviewed
in the EMR 3 weeks
after a patient visit.
Information about the
SFD process were
collected including
whether screening
tool was completed,
whether the provider
signed the tool,
whether a note was
written about
discussion of
screening tool, which
provider led
conversation with the

Variables
Studied and
Their
Definitions
IV: SFD
program
DV1: Screening
rate

6 oncologists,
7 nurses, and
3 administrators
were interviewed

DV2: Rate of
patient screened
and discussed
tool with HCP

Setting:
Head and neck and
neuro-oncology
clinics in Calgary,
Alberta

DV3: Rate of
patient screened
scored above
cutoff and
intervention was
indicated
DV4:
Conversations
between patients
and nurses

Measurement

Data
Analysis

16 semistructured
interviews
with
administrators,
physicians,
and nurses to
evaluate the
barriers and
support of
sustainability

Percentage

Chart review
of completed
screening
tools:
Edmonton
Symptom
Assessment
System
Canadian
Problem
Checklist

Qualitative
data from
healthcare
staff
interviews to
identify
themes
-data
transcribed
into QSR
NVivo 10®
software to
identify,
analyze, and
report themes
within the
data

Findings

DV1: 88.6%
DV2: 79.8%
DV3: 76.4%
DV4: 99.2%

5 themes
influencing
sustainability:
-Attitudes,
knowledge, and
beliefs about the
program
-Implementation
approach
-Outcome
expectancy of
providers
-Integration with
existing practice
-External factors

Appraisal: Worth to
Practice

Quality of Evidence:
Level III, B
Worth to Practice:
-SFD programs can be
used as a standardized
approach to screening
psychosocial, practical,
and physical factors to
improve patients' level
of distress and quality
of life
-Sustainability of the
program is attained
when it is standardized
and part of the culture
in a practice setting
-It is essential to
complete screenings at
the initial visit and
follow-up visits
-SFD program provides
an opportunity for
patients to improve
communication with
HCP
Strengths:
-SFD program can fill
current gaps in
knowledge and provide
the opportunity to
clarify the role provider
within the program
-Flow diagram is clear
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patient, and if there
were
interventions/referral
s recorded
Interviews with
healthcare staff were
recorded and
transcribed to
identify and analyze
themes
Conceptual
Framework:
Sustainability Model

depicting chart review
findings
Weaknesses:
-Research conducted at
a single point in time
-Quantitative data
obtained from patient
charts and it is possible
that HCP did not chart
an intervention
Feasibility:
Sustainability of SFD
program is feasible if it
is well integrated into
practice, while it is also
well perceived by
HCP.
Conclusion(s):
-SFD program was
well accepted by HCP
-Better educational
support and training is
needed during the
implementation
process of the SFD
program to HCP
acquire the knowledge
and skills
-Barriers to
sustainability include
competing priorities
(e.g., time
management) and lack
of commitment by
senior leadership.
Recommendation(s):

36
-Gaps in knowledge
can be addressed with
proper education, skill
training, and in-service
training

IV-IndepenIV: Independent variable; DV: Dependent variable; SFD: Screening for distress; EMR: Electronic medical record; HCP: Healthcare provider
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Citation

Hui et al.,
2017

Study Design/
Method

Sample/
Setting

Study Design:
QI Project,
Before and after
comparison,
Cohort design to
study the effect of a
pilot distress
screening program

Sample:
379
(preimplementation)
328 (training),
465 (postimplementation)
consecutive
cancer patients

Method:
A steering committee
was created to
supervise the
implementation
process, which
included medical
oncologists, social
workers, case
managers, clinical
nurses, and palliative
team.

Setting:
General Medical
Oncology
Outpatient Clinic
at Lyndon B.
Johnson Hospital
providing care to
underserved
patients in Harris
County, Texas.

Variables
Studied and
Their
Definitions
IV1:
Intervention
DV1: ESAS
completed
DV2: Social
work referrals
DV4:
Palliative care
referrals

Measurement

ESAS assess 10
physical and
emotional
symptoms using
an 11-point
numeric rating
scales
0 (no symptom)
to 10(worse).
ESAS cutoff
score ≥4 means
further
assessment is
needed

3 phases

-8 target
symptoms:
Pain, fatigue,
nausea,
drowsiness,
shortness of
breath, and
appetite

1) Preimplementation
(September 2015):
Patients received a
paper copy of ESAS
immediately after

Patient
demographics
retrieved
retrospectively
-Age
-Sex

Data
Analysis

Findings

Appraisal: Worth to
Practice

Descriptive
statistics
(Percentages
and means)
Chi-square
test
Fisher's
exact test

Patient
characteristics:
Majority of
participants
were either
female, of
Hispanic
origin, had
breast and
gastrointestinal
malignancies,
or were in
advanced
stages of
cancer (stage
III or IV)

Quality of Evidence: Level
II-B

Compliance
with ESAS:
83% (pre),
91% (training),
96% (post),
p<.001.
Social work
referrals: 21%
(pre), 71%
(training), 79%
(post), p<.001.

Worth to Practice:
-Orientation, education, and
feedback helped clinicians
adopt ESAS into their
routine care efficiently
-Routine distress screening
is vital especially in low
socioeconomic populations,
because they are less likely
to report symptoms
Strengths:
-Large sample size,
consecutive patient cohorts
-Provided
algorithm/blueprint of
distress screening
-ESAS is a validated and
reliable instrument in 20
different languages that is
widely used in clinical and
research settings
-Chart audits to monitor
ESAS documentation and
clinical interventions
-Offered staff feedback to
improve the program
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checking in during
their clinic visit. This
phase was designed to
grasp patients'
baseline distress
levels
2) Training (October
and November 2015):
Nursing staff received
a 15-minute
orientation on distress
screening practice.
Patients that met the
criterion for distress
were triaged by clinic
nurses and followed
up by social workers
to confirm severe
symptom distress.
Patients that continue
to experience distress
were offered services,
such as palliative,
psychiatric, or
psychological care).
Weekly meetings with
staff were held to
safeguard proper
screening process and
triage.
3) Postimplementation
(December 2015):
Reinforcement of
program by steering
committee; monitor
ESAS charting,
distress levels, and

-Race
-Cancer diagnosis
-Cancer stage

Palliative care
referrals:
12% (pre),
20% (training),
28% (post),
p=.21.

Weaknesses:
-Only one social worker
was involved in the study,
which limited the number
of patients triaged
-Some patients that
screened positive for
distress did not complete a
social work evaluation,
because the social worker
was unavailable to carry out
screening within a 48-hour
timeframe or the social
worker did not receive
referral notification from
the nurse
-Study was conducted in
one clinical setting so it
limits generalizability of
results
Feasibility:
DSP is feasible if social
work, palliative care, and
psycho-oncology services
are readily available in the
practice setting. The
triaging and referral process
in this study were created to
supplement the current
practice.
-EAS screening was
perceived well by patients
Conclusion(s):
-Social work triage process
showed that 30% of
positively screened patients
could not be contacted and
20% previously had their
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appropriate
interventions
Conceptual
Framework: None

concerns addressed by
oncologists
-DSP significantly
increased number of social
work referrals
-From pre-to-post
implementation, there was
an increase in symptom
distress documented using
ESAS
-Clinicians showed
increased adherence to DSP
-Implementation of DSP
can be successful through
collaboration by the
interdisciplinary team
Recommendation(s):
-Electronic alerts of
referrals may help increase
the rate of social work
assessments
-Or creating alerts in the
EMR to inform clinicians if
patients screen positive

IV: Independent variable; DV: Dependent variable; ESAS: Edmonton Symptom Assessment System; DSP: Distress screening program; EMR: Electronic
medical record
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Citation

Study Design/
Method

Sample/
Setting

Knies et
al., 2019

Longitudinal, preand-posttest,
mixed methods,
cohort, qualitative
and quantitative
design

N=36 Cancer
care clinicians
from 18
institutions that
were recruited
from online
advertisements

The purpose of
the study is to
identify barriers
and facilitators to
a 2-year SPDP
Interventions
included an
introductory kick
off meeting,
bimonthly
conferences,
quarterly
meetings for
problem solving
and support meetings
consisted of
presentations and
group work.

Setting:
National Cancer
Institute
Designated/
Comprehensive
Cancer Centers,
community/
general
hospitals

Variables
Studied and
Their
Definitions
IV: Cancer care
clinicians
DV: SPDP

Measurement

-Rate of goal
achievement
measured at 6-,
12-, and 24months postintervention
using an
investigator
developed Goal
Evaluation
Form
-Staff
interviews to
determine
distress
screening goals,
institutional
barriers, and
facilitators, as
well as
perceived
benefits of the
SPDP

Data Analysis

The most common
goal by clinicians
was creating
stakeholder buy-in
(n=12)
Goal achievement
were 25.9%, 65.5%,
and 94.8% at 6, 12,
and 24 months
Top 3 barriers:
-Lack of staff
(n=15)
-Staff turnover
(n=11)
-Competed
demands (n=11)

Findings

Participants report
that conference
calls/collaboration
with peers was
integral to
achieving their
goals
SPDP are beneficial
to achieve CoC’s
distress screening
standards

Facilitators:
-Buy-in (40.2%)
-Institution support
(14.8%)
-Dyad perceived as
knowledgeable
resource (12.2%)

IV: Independent variable; DV: Dependent Variable; PWC: Patients with Cancer; SPDP: Screening for Psychosocial Distress Program

Appraisal: Worth to
Practice

Quality of Evidence:
Level II, B
Strengths:
-Multi-institutional
study, increasing
generalizability
-Longitudinal design
-Consistent
recommendations
Weaknesses:
-Small sample size
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Citation

Study Design/
Method

Riba et al., 2019

Updated clinical
practice
guideline on
distress
screening
containing
RCTs, SRs

Sample/
Setting

-Clinicians
caring for PWC
Setting: Cancer
community
centers

Variables
Studied and
Their
Definitions
IV: Screening
DV:
Referrals/interve
ntions

Measurement

Data Analysis

Findings

Methods used to
implement
guidelines

Qualitative
synthesis of
selected articles

-There is stigma
associated with
psychological
issues especially
when using
words, such as
“psychiatric,”
“psychological,”
or “emotional.”

20-52% of PWC
experience a
significant level
of distress

-Stigmatization
leads to
underreported by
patients of their
feelings of
distress
-Updated
guidelines will
help improve
delivery of
patient-centered
care and patient
QOL
-Screening
patients alone are
not sufficient
without proper
referral,
treatment, and
follow-up
-Earlier referrals
were linked to

Appraisal:
Worth to
Practice
Quality of
Evidence:
Level IV, A
Strengths:
-Includes RCTs
-Appropriate
stakeholders
involved in
development of
CPGs
-Elimination of
potential bias
-Valid and clear
recommendations
supported by
evidence
-Guidelines are
frequently
updated
-Knowledgeable
multidisciplinary
panel of experts
-No risk for bias
-Consistent results
Weaknesses:
None noted
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improved
outcomes
-DT is a well
validated tool for
distress
screening

IV: Independent variable; DV: Dependent Variable; PWC: Patients with Cancer; CPG: Clinical Practice Guidelines; RCT: Randomized controlled trial; SR:
Systematic Review; QOL: Quality of life; DT: Distress thermometer

43
Citation

Tonsing, K. N.,
&
Vungkhanching,
M. (2018)

Study Design/
Method

Sample/
Setting

Study Design:
RCT, Cohort
Study during
May 2014

N=43 cancer
patients
receiving
treatment

Method:
Participants were
screened for
psychosocial
distress
experienced in
the past week by
social workers
with the DT and
PC then received
referrals if
necessary

Setting:
Outpatient
cancer treatment
center in Central
California

Conceptual
Framework:
None
Evaluate the
feasibility of a
DT in
conjunction with
a PC as a
psychosocial
distress
screening tool
Secondary
purpose is to
assess the
relationship of
the DT with PC

Inclusion
criteria:
-Patients at least
18 years of age
-Englishspeaking
-Capable of
giving written
consent
-Receiving
treatment
Attrition: NR

Variables
Studied and
Their
Definitions
IV1: DT with PC
IV3: Patient's
demographic
information:
Age, gender,
race, reported
health insurance,
and cancer
diagnosis
DV1: Distress
factors

Measurement

DT included a
thermometer
with a number
scale from 0 (no
distress) to 10
(extreme
distress)
DT cutoff score:
4
Score <4 = not
distressed
Score>4 =
distressed

DV2: Feasibility
PC consisted of
39 items of
probable distress
experienced by
participants
categorized as:
Practical
problems, family
problems,
emotional
problems,
spiritual/religiou
s problems, and
physical
problems
Demographic
sheet
documented
patient age,
gender, race,

Data Analysis

-Frequency
-Mean score
-Percentage
-Chi-square
-t-tests

Findings

DV1 >4 for
51.2% (n=22) of
the participants
Mean DT scores
for IV1
(M=9.23) were
significantly
higher than IV2
(M=2.76)
Main reasons of
distress:
-Practical
-Emotional
-Physical
Significantly
higher number of
practical
problems in
distressed group
Distressed
patients had
higher frequency
of emotional and
physical
problems
-Nervousness
(45.5%)
-Worry (40.9%)
-Fears (40.9%)
-Sadness
(36.4%)
-Pain (54.5%)

Appraisal:
Worth to
Practice
Level of
Evidence
(Critical
Appraisal
Score): I-B
Worth to
Practice:
-Essential to
consider
distressing factors
when assessing
psychosocial
distress levels
-Distress levels
can affect patient
satisfaction,
compliance with
treatment, and
decision-making
-Identifying
sources of distress
will allow
providers to
provide
appropriate
interventions and
psychosocial
referral
Strengths:
-No conflicts of
interest
-Provided
possible sources
of distress
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scores,
demographic and
clinical
characteristics
between
distressed and
non-distressed
participants

health insurance,
and cancer
diagnosis

-Fatigue (45.5%)
-Sleep problem
(45.5%)
-No significant
relationship
between DT
scores and
demographic and
clinical factors

-Research design
and collection
method clearly
stated
-The ability to
screen for distress
and sources of
distress using DT
and PC screening
tool
Weaknesses:
-Small sample
size
-Validity of
instrument not
discussed
-Lack of diversity
in participants
-Results limit
generalizability
-Interventions led
by social workers
that might limit
access to care
Conclusion(s):
-DT and PC
screening tool is
practical and
allows providers
to identify sources
of distress
Feasibility:
DT and PC is
reasonable to
implement
Recommendatio

45
n(s):
-Further research
on patient
acceptability of
DT and PC
-Future studies
with larger
sample size
-More
information
needed to study
the relationship
between
interventions/refer
rals and lower
levels of distress
Include in
project? Yes

Definition of abbreviations: RCT – Randomized controlled trial; IV-Independent variable; DV- Dependent variable; DT-Distress thermometer; PC-Problem
checklist; NR – Not reported
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Citation

Y. Wang et al.,

Study Design/
Method

Study Design:
Cohort,
Cross-sectional,
cluster study
conducted
between April 9April 19,, 2020
Method:
Patients were
recruited by the
cancer center
through mobile
messaging with a
website to
complete a
survey. They
were provided an
information
sheet and
consent)
Conceptual
Framework:
None
Investigate
mental health
problems in
cancer patients
through the
COVID-19
pandemic

Sample/
Setting

N Sample:
N= 6213 cancer
patients (out of
9978 invited)
Setting:
Sun Yat-Sen
University
Cancer Center,
China

Exclusion
Criteria:
Incomplete
surveys, surveys
with invalid
information

Variables
Studied and
Their
Definitions
IV1: Survey
IV2:COVID-19
related risks
IV3:
Psychosomatics
factors
DV: Mental
health outcomes

Measurement

Sociodemographic
and clinical
characteristics:
-Age
-Sex
-Residence
-Annual family
income
-Education
-Marital status
-Employment
status
-Mental health
history
(diagnosed by
psychiatrist)
-Alcohol intake
during pandemic
measured by
symptom level
(4-point Likert
scale to measure
intake
frequency)
-Medical
conditions were
obtained from
EMR
Frequency of
worry regarding
cancer
management due
to COVID-19
-Likert scale

Data Analysis

Frequency
Percentages
Regression
models

Findings

Prevalence
Depression:
23.4%
Anxiety: 17.7%
PTSD: 9.3%
Hostility: 13.5%

Appraisal:
Worth to
Practice
Level of
Evidence
(Critical
Appraisal
Score): III-B

Inconveniences
to receive
treatment was
associated with
higher risk of
depression
(b=0.043,
p<0.01).

Worth to
Practice:
-Early detection
of mental health
problems for
susceptible cancer
patients can
improve longterm mental
health state
-COVID-19
presents as an
additional burden
to cancer patients
-Within this
study, there is a
gap between high
prevalence of
mental health
problems and low
prevalence of
intervention

High levels of
PTSD symptoms
were associated
with longer time
since diagnosis
(b=0.035,p<0.01
) and high

Strengths:
-No conflicts of
interest
-One of the first
few studies
regarding mental
health of cancer

36% of patients
had difficulties
continuing
cancer therapy
because of
inconveniences
from COVID-19
2.6% of the
participants had
history of mental
disorder
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from 1(never) to
5(very often)
Barriers to
accessing
treatment during
COVID-19
-1 (no barriers)
to 4 (severe
barriers)
Frequency of
feeling
overwhelming
psychological
pressure due to
COVID-19
-1(never) to
5(very often)
Psychosomatic
characteristics:
Fatigue and pain
measured using a
VAS
Quality of life
and degree of
satisfaction
about physical
health
- WHOQOLBRIEF
assessment tool
1(extremely
unsatisfied) to
5(extremely
satisfied)
Sleep quality –

frequency of
receiving
COVID-19
information and
news
(b=0.021,p<0.05
).
Risk factors:
-History of
mental health
disorder
-Excessive
alcohol use
-High levels of
fatigue and pain
Protective
factors:
-Better QOL
-Good
relationships
with family
-Younger age
(against hostility)
Lower risk of
anxiety
associated with:
-Younger age
(b=-0.028,
p<0.01)
-Male sex (b=0.031, p<0.01)
-Being employed
(b=-0.030,
p<0.01)
-Longer time
since diagnosis
(b=-0.023,

patients during
COVID-19
-Clear stated
research question
with robust data
analysis
-Results identified
risk factors as
well as protective
factors for mental
health problems
Weaknesses:
-Cross-sectional
design limits
causality in
variables
-Self-report
questionnaires by
patients may
increase risk of
bias and decrease
reliability
Feasibility:
-Electronic mental
health screening
is feasible
especially in the
time of COVID.
However, it is
essential to
consider patients
that lack the
technology or
technological
skills.
Conclusion(s):
- During the
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DSMIVInsomnia
Criteria
Social support
and
interpersonal
relationships
-Quality of
relationship with
friends and
family ranging
from 1(very bad)
to 5(very good)
Social support
Ranging from
1(no) to 4(very
much)
Mental health
outcomes
-Anxiety –
GAD-7 on a 4point Likert scale
-Depression –
PHQ-9 on a 4point Likert scale
Hostility – BSI
PTSD-IES-R (a
22-item 5-point
Likert scale)
Frequency of
psychological or
psychiatric
counseling
services use and
attitudes

p<0.05)
-Receiving
treatment (b=0.048, p<0.001)
-Higher
frequency of
receiving
COVID-19
information and
news (b=-0.027,
p<0.01)
-Satisfaction
with personal
health (b=-0.049,
p<0.001)
-Good sleep
quality (b=0.158, p<0.001)
-Good
relationship with
friends (b=0.025, p<0.05)
Lower levels of
depression were
associated with:
-Employment
(b=0.048,p<0.001)
-Longer time
since diagnosis
(b=0.024,p<0.01)
-Good sleep
quality (b=0.203,p<0.001)
Lower levels of
PTSD symptoms
were associated

COVID-19
pandemic, cancer
patients are more
likely to
experience higher
levels of mental
health symptoms
-The study
revealed only a
small number of
patients sought
psychological
care
-It is vital to
screen high risk
groups for mental
health problems
so they can
promptly receive
adequate
treatment to
manage their
mental health
symptoms
-More
collaboration
between
stakeholders is
needed to create
psychooncological care
Recommendatio
n(s):
-Study findings
can be integrated
into the DNP
project to assess
different factors
contributing to
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with:
-Male sex (b=0.058,p<0.001)
-Good sleep
quality (b=0.251,p<0.001)
-Good
relationship with
friends (b=0.062,p<0.001)
Only 1.6% of
patients sought
psychological
counseling,
48.1% did not
care for online
mental health
services, and
11.2% perceived
online mental
health services to
be beneficial
Female patients
had increased
frequency of
worrying about
disease
management
because of
COVID-19
(t=2.13,p<0.05);
increased
psychological
pressure due to
COVID-19
(t=6.65,
p<0.001); lower
sleep quality (t=-

distress related to
COVID-19
Include in
project? Yes
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4.15,p<0.001).

Definition of abbreviations: RCT – Randomized controlled trial; IV-Independent variable; DV- Dependent variable; DT-Distress thermometer; PC-Problem
checklist; NR – Not reported
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Citation

Zebrack et al.,
2015

Study Design/
Method

Retrospective,
quantitative
study to assess
the fidelity of
distress
screening
protocols in 12
weeks

Sample/
Setting

N=583 PWC
extracted from
EMRs
Setting: Two
tertiary cancer
care treatment
centers

Variables
Studied and
Their
Definitions
IV: Patients with
DT scores
DV1: Rates of
adherence

Measurement

-Adherence to
protocol
-Responsiveness
-Acceptability

DV2:
Responsiveness
to patients with a
significant level
of distress based
on DT score
DV3: Clinician
acceptability

(Analyzed via
counts,
percentages, and
means)

Data Analysis

Findings

Overall
adherence rate
was 69.2% while
rates ranged
from 63.8% to
73.3% across
clinics

Ranging from
14.7% to 36% of
clinicians across
clinics report the
protocol slows
down clinic
operations

More female
patients (64.7%)
had DT
screening when
compared with
male patients
(57.2%)

40% to 80.4% of
clinicians believe
screening is
beneficial for
patients to
receive
appropriate
follow-up care

Documentation
of psychosocial
services/referral
averaged 50%63% when DT
scores were high
(level 8-10)

44% 89.5%
report the
protocol helps
address patient
issues

Feedback
regarding the
distress
screening
protocol were
mostly positive

Implementation
of protocol was
successful likely
due to training,
preparation, and
coordination of
providers
(collaboration)
Recommendatio
ns to ensure
vulnerable
subpopulations

Appraisal:
Worth to
Practice
Quality of
Evidence:
Level II, B
Strengths:
-Multicenter
study
-Use of validated
tool
Weaknesses
-Retrospective
design relying on
data from EMR
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are not excluded
from being
screened (e.g.,
non-English
speakers)
Adherence and
responsiveness
may be enhanced
from staff
feedback,
continued
training, and
adaptation to
protocol
Screening alone
is not beneficial
without
appropriate
interventions to
follow

IV: Independent variable; DV: Dependent Variable; PWC: Patients with Cancer; DT: Distress thermometer; EMR: Electronic medical record
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Appendix B: Biopsychosocial Model

(Perspectives Clinic, n.d.)
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Appendix C: Statement of Determination

Doctor of Nursing Practice
Statement of Non-Research Determination (SOD) Form

General Information
Last Name:
CWID Number:
Course Name & Number:

Cheung
First Name:
11327865
Semester/Year:
NURS 749B Qualifying Project

Chairperson Name: Dr. Jodie Sandhu
Second Reader Name: Dr. Victoria Chaudhary

Candy
Spring 2021

Advisor Name: Dr. Jodie Sandhu

Project Description
1. Title of Project: Implementation of a Nurse Practitioner-Led Psychosocial Distress Screening
Tool Among Hematology Patients During COVID-19 Pandemic
2. Brief Description of Project:
Hematology patients are recognized as an immunocompromised and vulnerable group facing the
ongoing physical and emotional burden of cancer. The National Comprehensive Cancer Network
(NCCN) developed a guideline recommending routine screening for distress among patients with
cancer, given the prevalence of distress experienced by the population. Nonetheless, distress
screening tools are underutilized, and screening rates are suboptimal. The emergence of the
coronavirus disease 2019 (COVID-19), an infectious disease caused by a severe acute respiratory
syndrome coronavirus 2 (SARS-CoV2), has profoundly shifted the way health care providers
deliver care to cancer patients, as the population faces lockdown measures, social isolation, and
uncertainty. The psychological impact of the COVID-19 pandemic adds an emotional burden as
people are suffering more stress, anxiety, and depression worldwide. Undetected and untreated
psychosocial distress can lead to undesirable health outcomes, including decreased survival rate,
delay in treatment, reduced treatment adherence, and increased healthcare expenditure.
Additionally, considering the population's high susceptibility, COVID-19 can produce an
increased risk of psychosocial distress among hematological patients and potentially contribute to
increased morbidity and mortality. The purpose of this project is to emphasize the importance of
screening, monitoring, and treating psychosocial distress in hematological patients to preserve
their health-related quality of life.
3. AIM Statement:
From September 2021 to December 2021, UCSF's hematology NPs will increase the percentage of
psychosocial distress screening among adult hematology patients at the ambulatory infusion center by
25% through:
o Increasing clinician knowledge on the importance of administering screening tool
o Increasing clinician compliance of administering screening tool
o Increasing the number of referrals for psycho-oncological/psychiatric/social work services for
at-risk patients through implementing a distress screening training program.

55

4. Brief Description of Intervention:

The project's interventions will include conducting a pre-intervention survey to assess clinicians'
current practices and knowledge about distress screening, followed by educating NPs on the
importance of distress screening. Education sessions will be completed during staff meetings. Atrisk patients will be followed up and will be offered referrals if necessary.
4a. How will this intervention be implemented?
• Where will you implement the project?
o UCSF outpatient hematology clinic
•

Attach a letter from the agency with approval of your project.

•

Who is the focus of the intervention?
o The focus of the intervention will be hematology patients.

•

How will you inform stakeholders/participants about the project and the intervention?
o This will be done through an education session during staff meetings, and participants
will be introduced to the questionnaire during their clinic visits.

5. Outcome measurements: How will you know that a change is an improvement?
• Measurement over time is essential to QI. Measures can be outcome, process, or balancing
measures. Baseline or benchmark data are needed to show improvement.
o To evaluate the tool’s effectiveness, a pre-and-post-intervention survey will be
distributed to clinicians to assess their knowledge and perceived efficacy of the screening
tool.
•

Align your measure with your problem statement and aim.
o Independent variable: screening tool
o Dependent variable: distress level
o DV2: screening rates
o DV3: screening efficacy

•

Try to define your measure as a numerator/denominator.
o The percentage of patients screened divided by the total number of patients served during
the project period.
o The percentage of patients that actually received referrals divided by the number of
patients that are at-risk based on screening results

•

What is the reliability and validity of the measure?
o Provide any tools that you will use as appendices. Distress Thermometer is a validated
and reliable tool recommended by the NCCN. (see Appendix C)

•

Describe how you will protect participant confidentiality.
o Patient identifiers on the questionnaire will be removed by clinicians after completion of
the questionnaire and patient received appropriate care depending on if they screened
negative/positive, declined referral, or accepted referral.
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DNP Statement of Determination
Evidence-Based Change of Practice Project Checklist
Project Title: Implementation of a Nurse Practitioner-Led Psychosocial Distress Screening Tool

Among Hematological Patients During COVID-19 Pandemic
Mark an "X" under "Yes" or "No" for each of the following statements:
The aim of the project is to improve the process or delivery of care with established/ accepted standards, or
to implement evidence-based change. There is no intention of using the data for research purposes.

Yes
X

The specific aim is to improve performance on a specific service or program and is a part of usual care.
All participants will receive standard of care.

X

The project is not designed to follow a research design, e.g., hypothesis testing or group comparison,
randomization, control groups, prospective comparison groups, cross-sectional, case control). The project
does not follow a protocol that overrides clinical decision-making.

X

The project involves implementation of established and tested quality standards and/or systematic
monitoring, assessment or evaluation of the organization to ensure that existing quality standards are being
met. The project does not develop paradigms or untested methods or new untested standards.

X

The project involves implementation of care practices and interventions that are consensus-based or
evidence-based. The project does not seek to test an intervention that is beyond current science and
experience.

X

The project is conducted by staff where the project will take place and involves staff who are working at an
agency that has an agreement with USF SONHP.

X

The project has no funding from federal agencies or research-focused organizations and is not receiving
funding for implementation research.

X

The agency or clinical practice unit agrees that this is a project that will be implemented to improve the
process or delivery of care, i.e., not a personal research project that is dependent upon the voluntary
participation of colleagues, students and/ or patients.

X

If there is an intent to, or possibility of publishing your work, you and supervising faculty and the agency
oversight committee are comfortable with the following statement in your methods section: "This project
was undertaken as an Evidence-based change of practice project at X hospital or agency and as such was
not formally supervised by the Institutional Review Board."

X

Answer Key:
• If the answer to all of these items is "Yes", the project can be considered an evidence-based activity that does not
meet the definition of research. IRB review is not required. Keep a copy of this checklist in your files.
• If the answer to any of these questions is "No", you must submit for IRB approval.
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human Research Committee, Partners
Health System, Boston, MA.

To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the criteria outlined in federal
guidelines will be used: http://answers.hhs.gov/ohrp/categories/1569

No
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DNP Statement of Determination
Evidence-Based Change of Practice Project Checklist Outcome
The SOD should be completed in NURS 7005 and NURS 791E/P or NURS 749/A/E
This project meets the guidelines for an Evidence-based Change in Practice Project as outlined in the Project
Checklist (attached). Student may proceed with implementation.
This project involves research with human subjects and must be submitted for IRB approval before project
activity can commence.

Comments:
Student
Last Name:

Cheung

Student Signature:
Chairperson Name:

Candy

Date:

March 28, 2021

Dr. Jodie Sandhu

Chairperson
Signature:
Second Reader
Name:
Second Reader
Signature:

Student
First Name:

Date:

Dr. Victoria Chaudhary

Date:

DNP SOD Review
Committee Member
Name:
DNP SOD Review
Committee Member
Signature:

Date:
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Appendix D: Letter of Support

DNP Project Letter of Support from Agency
This is a letter of support for Candy Cheung to implement her DNP
Comprehensive Project - Implementation of a Nurse Practitioner-Led
Psychosocial Distress Screening Tool Among Hematology Patients During
COVID-19 Pandemic at UCSF.
We give her permission to use the name of UCSF in her DNP Comprehensive
Project Paper and in future presentations and publications.
Sincerely,
Lisa McNey, NP
UCSF Hematology/Blood and Marrow Transplant Program
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Appendix E: NCCN Distress Thermometer

(NCCN Distress Thermometer for Patients, 2013)

60
AppendixPatient
F: Patient
Questionnaire
Questionnaire
You are invited to participate in a survey on a quality improvement project in implementing a distress
screening tool for hematology patients. This is a project being conducted by Candy Cheung, a student
at the University of San Francisco. It should take approximately 5-10 minutes to complete.
PARTICIPATION
Your participation in this survey is voluntary. You may refuse to take part in the project at any time
without penalty. You are free to decline to answer any particular question you do not wish to answer
for any reason.
BENEFITS
You will receive no direct benefits from participating in this quality improvement study. However,
your responses may help us learn more about the usefulness of the distress screening tool.
RISKS
There is the risk that some questions may cause emotional discomfort and may be distressing to you
as you think about your experiences.
CONFIDENTIALITY
Your survey answers will be transferred to Qualtrics where data will be stored in a password
protected electronic format. Qualtrics does not collect identifying information such as your name,
email address, or IP address. Therefore, your responses will remain anonymous. No one will be able
to identify you or your answers, and no one will know whether or not you participated in the study.
CONTACT
If you have questions at any time about the study or the procedures, you may contact the DNP
student, Candy Cheung via email at [ccheung3@dons.usfca.edu].

CONSENT: Please select your choice below. You may request a copy of this consent form for your

·

You have read the above information

·

You voluntarily agree to participate

Agree
Disagree
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Patient Questionnaire
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Patient Questionnaire
1) Age: ________
2) What gender do you identify as?
Male (including transgender men)
Female (including transgender women)
Prefer to self-describe as ___________ (non-binary, gender-fluid, agender, please specify)
Prefer not to say

3) Please specify your ethnicity.
Caucasian
African American
Latino/Hispanic
Asian

Native American
Native Hawaiian or Pacific Islander
Other, please specify ___________
Prefer not to say

5) Are you married/in a relationship?
Yes
No
Prefer not to say
8) What is your current employment status?
Employed Full-Time
Employed Part-Time
Seeking opportunities

Retired
Prefer not to say

9) Have you ever been diagnosed with COVID-19?
Yes

No

11) Have you ever been diagnosed with a mental health disorder?
Yes
No

12) If you responded 'yes' to the previous question, are you currently seeking treatment?
Yes

No

Comments/Feedback:

Thank you for your participation!
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Patient Questionnaire

Office Use Only
•
•
•
•
•

Patient identifier

Not needed
SW
Psych-Onc
Declined
Other __________

(Remove identifier after completion of screening/referral)
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Appendix G: Patient Pamphlet
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Appendix H: NP Education

Introduction
Implementation of a
Psychosocial Distress
Screening Tool Among
Hematology Patients During
the COVID-19 Pandemic

Name: Candy Cheung
School: University of San Francisco
Program: Doctor of Nursing Practice – FNP (4th year)
Project Chair: Dr. Jodie Sandhu, DNP – FNP
Project Co-Chair: Lisa McNey, MSN – NP
Work: UCSF inpatient 11/12L Heme/Onc/BMT RN

Candy Cheung
August 19th, 2021

1

2

Background

Survey

•

•
•

•

•
•

3

4

Rationale

Purpose

Biopsychosocial Model

• Considering the population's high susceptibility, COVID-19

can produce an additional risk of psychosocial distress
among hematology patients
o

•
•
•

Increased morbidity and mortality

Developed in 1977 by psychiatrist Dr. George Engel
More holistic approach compared to traditional biomedical approach
3 components: Biology, psychology and social

Undetected and untreated psychosocial distress can lead to
undesirable outcomes (Y. Wang et al., 2020)
o
o
o
o

Decreased survival rate
Delay in treatment
Decreased treatment adherence
Increased healthcare expenditure

• Essential to screen, monitor, and treat psychosocial

distress in hematology patients in the outpatient
hematology clinic to preserve their health-related quality
of life

5

6

1
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Key Stakeholders

Timeline
Project Kickoff Date: September 1st, 2021
Project End Date: December 1st, 2021
Duration: 3 months

7

Administrators
(nurse
managers)

Clinical staff
(nurse
practitioners,
oncologists,
registered
nurses,
psychooncologists)

Social
workers

Quality
department

Information
technology

Patients and
caregivers

8

Interventions
• Pre-and-post intervention survey
Via Qualtrics (QR code or email)
Paper version will also be available
Assess current knowledge and practices

•
•
•

• Screening tool will be printed and distributed
to patients during their clinic visits by NP
student
• NP student will inform clinicians of at-risk
patients
Follow-up and referrals will be completed if necessary

•

9

10

Patient COVID Questionnaire

Patient Questionnaire
1. Distributed as a physical print-out to each patient when
they check in for their in-person clinic visit (administered
once)
•

While the patients are waiting for their lab results, they have time to
complete the questionnaire

•

Questionnaire includes patient demographics

2. After the screening is completed, the DNP student will
deliver the results to the assigned clinician for review and
interpretation.

11

Based on the DT results, the clinician will check off the
appropriate boxes on the top left corner indicating the
interventions that were made for the patient during that time.
The DNP student will collect all screening forms, remove the
patient identifiers to ensure confidentiality.

12

2
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• Screen and monitor hematology patients for psychosocial distress to
ensure that they are provided with appropriate psycho-oncological care
to address their needs and preserve their mental health.
• Patients are less likely to express their psychosocial needs openly if
clinicians do not address it in the first place (Buxton et al., 2014).
• Evidence from the literature supports incorporating a validated
psychosocial distress screening tool to increase screening rates and
remove barriers to delivery of psycho-oncological care.
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Appendix I: NP Pre-Intervention Survey
You are invited to participate in an online survey on a quality improvement project in
implementing a distress screening tool for hematology patients. This is a project being
conducted by Candy Cheung, a student at the University of San Francisco. It should take
approximately 5 minutes to complete.
PARTICIPATION
Your participation in this survey is voluntary. You may refuse to take part in the study or exit
the survey at any time without penalty. You are free to decline to answer any particular
question you do not wish to answer for any reason.
BENEFITS
You will receive no direct benefits from participating in this quality improvement
study. However, your responses may help us learn more about the usefulness of the distress
screening tool.
RISKS
There are no foreseeable risks involved in participating in this project.
CONFIDENTIALITY
Your survey answers will be transferred to Qualtrics where data will be stored in a passwordprotected electronic format. Qualtrics does not collect identifying information such as your
name, email address, or IP address. Therefore, your responses will remain anonymous. No one
will be able to identify you or your answers, and no one will know whether or not you
participated in the study.
CONTACT
If you have questions at any time about the study or the procedures, you may contact the DNP
student, Candy Cheung via email at [ccheung3@dons.usfca.edu].
ELECTRONIC CONSENT: Please select your choice below. You may print a copy of this consent
form for your records. Clicking on the “Agree” button indicates that
· You have read the above information
· You voluntarily agree to participate

£ Agree
£ Disagree
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1) Are you aware of the National Comprehensive Cancer Network’s recommendations to
screen patients with care for distress?
£

Yes

£

No

2) How often do you screen patients for psychosocial distress?
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£
£
£

Always
Most of the time
About half the time

£
£

Sometimes
Never

3) Are you aware of the Commission on Cancer of the American College of Surgeons
accreditation standards requiring practices to screen cancer patients for
psychosocial distress?
£

Yes

£

No

4) I think it is important to screen patients for distress.
£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

5) The COVID-19 pandemic has had a significant negative impact on hematology patients.
£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

6) I am aware there is a distress screening tool in EPIC.
£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

7) I think it is important to have a distress screening tool accessible for our patients.
£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

8) Are you aware of the psycho-oncological care and social work services available for
patients?
£

Yes

£

No

9) How often do you make psycho-oncological referrals?
£
£
£

Always
Most of the time
About half the time

£
£

Sometimes
Never
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10) How often do you reach out to social work services for assistance?
£
£
£

Always
Most of the time
About half the time

£
£

Sometimes
Never

We thank you for your time spent on this survey.
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Appendix J: NP Post-Intervention Survey
You are invited to participate in an online survey on a quality improvement project in
implementing a distress screening tool for hematology patients. This is a project being
conducted by Candy Cheung, a student at the University of San Francisco. It should take
approximately 5 minutes to complete.
PARTICIPATION
Your participation in this survey is voluntary. You may refuse to take part in the study or exit
the survey at any time without penalty. You are free to decline to answer any particular
question you do not wish to answer for any reason.
BENEFITS
You will receive no direct benefits from participating in this quality improvement
study. However, your responses may help us learn more about the usefulness of the distress
screening tool.
RISKS
There are no foreseeable risks involved in participating in this project.
CONFIDENTIALITY
Your survey answers will be transferred to Qualtrics where data will be stored in a passwordprotected electronic format. Qualtrics does not collect identifying information such as your
name, email address, or IP address. Therefore, your responses will remain anonymous. No one
will be able to identify you or your answers, and no one will know whether or not you
participated in the study.
CONTACT
If you have questions at any time about the study or the procedures, you may contact the DNP
student, Candy Cheung via email at [ccheung3@dons.usfca.edu].
ELECTRONIC CONSENT: Please select your choice below. You may print a copy of this consent
form for your records. Clicking on the “Agree” button indicates that
· You have read the above information
· You voluntarily agree to participate

£ Agree
£ Disagree
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1) How often did you screen patients for psychosocial distress in the past 6 months?
£
£
£

Always
Most of the time
About half the time

£
£

Sometimes
Never

2) I think it is important to screen patients for distress.
£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

3) The COVID-19 pandemic has had a significant negative impact on hematology patients.
£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

4) I think it is important to have a distress screening tool accessible for our patients.
£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

5) Are you aware of the psycho-oncological care and social work services available for
patients?
£

Yes

£

No

6) I thought the Distress Thermometer was an effective tool.
£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

7) I was able to identify more patients with distress using the Distress Thermometer
compared to pre-intervention.
£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

8) I was able to make more referrals to psycho-oncological services because of the Distress
Thermometer.
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£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

9) How often did you make psycho-oncological referrals during the project for at-risk
patients?
£
£
£

Always
Most of the time
About half the time

£
£

Sometimes
Never

10) I was able to reach out to social work more because of the Distress Thermometer.
£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

11) I will continue to use the Distress Thermometer on my patients.
£
£
£

Strongly agree
Somewhat agree
Neither agree or disagree

£
£

Somewhat disagree
Strongly disagree

12) The Distress Thermometer does not impede my workflow.
£ Strongly agree
£ Somewhat disagree
£ Somewhat agree
£ Strongly disagree
£ Neither agree or disagree
13) How easy was it to use the Distress Thermometer?
£
£
£

Extremely easy
Somewhat easy
Neither easy or difficulty

14) Comments/Feedback:

£
£

Somewhat difficult
Extremely difficult
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Appendix K: Gap Analysis
1.

There are no clinicians promoting best practice with distress screening.

2.

There are no distress screening education or training.

3.

No standardized distress screening tool in the outpatient hematology clinic.

4.

Lack of knowledge or awareness by clinicians on available screening tools.

5.

No data on adherence or compliance with distress screening in the outpatient
hematology clinic.

6.

Competing demands and workload may impact clinicians’ screening compliance or
adherence.
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Appendix L: Gantt Chart
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Appendix M: SWOT Analysis

Internal Factors
Strengths
•
•
•

•
•

Weaknesses

Trained and experienced hematology
staff
Academic medical center/Magnet
Hospital
Available clinical resources and
interdisciplinary team (e.g., social
worker, psycho-oncology services)
Supportive staff and leadership
Collaborative care

•
•
•
•
•
•
•
•
•
•

Lack of knowledge regarding current
distress screening recommendations
No policy or protocol concerning
distress screening
Increased clinician workload
Time constraints
Patient self-reporting on screening tool
may impact reliability
Paper screening tool may not be as
practical as documentation in the EMR
Screening tool only available in the
English language
Staffing shortages
Staff dissatisfaction
Reluctance by staff

External Factors
Opportunities
•

•
•
•
•
•
•

The NCCN recommends distress
screening among oncology patients in
all healthcare settings
Improved patient care
Increased patient satisfaction
Improve patient outcomes
Standardize training and nursing care
in distress screening
Improve referral system
Improve staff-patient communication

Threats
•

•
•

Potential changes in local, national,
and global guidelines in distress
screening
Potential cost
COVID-19 pandemic changes
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Appendix N: Work Breakdown Structure (Table Format)
Level 1
1. Psychosocial
Distress
Screening
Implementation
in the
Hematology
Clinic

Level 2
1.1 Initiation

Level 3
1.1.1 Meet with organization to discuss proposed project,
conduct needs assessment and finalize project site
1.1.2 Develop Project Charter
1.1.3 Deliver Project Charter
1.1.4 Organization Reviews Project Charter
1.1.5 Project Charter Approved

1.2 Planning

1.2.1 Determine Project Team
1.2.2 Project Team Kickoff Meeting
1.2.3 Develop Project Plan
1.2.4 Submit Project Plan
1.2.5 Project Plan Approval
1.3.1 Project Kickoff Meeting
1.3.2 Review and Validate Instrument/Tools
1.3.3 Develop Psychosocial Distress Screening Interventions
1.3.4 Determine Sample Size
1.3.5 Testing Phase
1.3.6 Finalize Project Interventions
1.3.7 Training/Education for Staff
1.3.8 Go Live
1.4.1 Project Management
1.4.2 Project Status Meetings
1.4.3 Risk Management
1.4.4 Update Project Management Plan
1.5.1 Audit Procurement
1.5.2 Document Lessons Learned
1.5.3 Update Files/Records
1.5.4 Gain Formal Acceptance
1.5.5 Archive Files/Documents

1.3 Execution

1.4 Control

1.5 Closeout
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Appendix O: Work Breakdown Structure (Hierarchy Format)
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Appendix P: Proposed Budget

Type of Expense

Cost

Staff pre-and-post intervention
survey (Online)

$0

Patient screening and COVID
questionnaire (printing)

$130

Patient brochure

$250

Estimated Total

$380
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Appendix Q: Communication Matrix
Purpose

Kickoff meeting

Medium

Frequency

Audience

-Introduce project
-Confirm objectives,
goals, and deliverables
as needed

Virtual staff meeting
(Zoom link for those
unable to attend inperson)

-Once at the start of project

-Project team
-Project sponsors
-Stakeholders

-Review status of
project

Zoom meeting/phone
call

Monthly

Project team

Check-ins/Meeting
recap

Update stakeholders on
the project status

Email

Monthly

-Project sponsor
-Stakeholders

Project status
meetings

Update leadership on
project status and give
opportunity to ask
questions

Zoom meeting

Monthly

-Project manager
-Project sponsor
-Stakeholders

Project Review

Give stakeholders
opportunity to provide
feedback on project

Email with survey

Once after project is
complete

-Project manager
-Project sponsor
-Stakeholders

Project Team
Meetings
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Appendix R: Pre-Intervention NP Results
Are you aware of the National
Comprehensive Cancer Network’s
recommendations to screen patients with
care for distress?

Are you aware of the Commission on
Cancer of the American College of
Surgeons accreditation standards
requiring practices to screen cancer
patients for psychosocial distress?

50%

50%

90.00%
80.00%
70.00%
60.00%
50.00%
40.00%
30.00%
20.00%
10.00%
0.00%

No

35.00%
30.00%
25.00%
20.00%
15.00%
10.00%
5.00%
0.00%
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gr
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gr
ee
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ew
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t…
ng
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l

ya
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e
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er
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e…
m
ew
ha
t…
Di
sa
gr
ee
St
ro
ng
ly…

100.00%
80.00%
60.00%
40.00%
20.00%
0.00%

Neither Disagree Strongly
agree
disagree
nor
disagree

I am aware there is a distress screening
tool in EPIC

St
ro
ng
l

The COVID-19 pandemic has had a
significant negative impact on
hematology patients.

Ne
ve
r

I think it is important to screen patients
for distress.

Strongly Agree
agree
Yes

So
m
et
im
es

tim
e
he

ha
lf
t

Ab
ou
t

M
os
t

of
t

Al
w
ay
s

No

67%

tim
e

Yes

35.00%
30.00%
25.00%
20.00%
15.00%
10.00%
5.00%
0.00%
he

33%

How often do you screen patients for
psychosocial distress?
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I think it is important to have a distress
screening tool accessible for our
patients.

Are you aware of the psycho-oncological
care and social work services available
for patients?

100.00%
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0.00%
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0%
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l

100%
Yes

How often do you make psychooncological referrals?

How often do you reach out to social
work services for assistance?
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r

he
…
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ha
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t
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e
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t

he

of
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40.00%
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0.00%

No
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Appendix S: Post-Intervention NP Results

How often did you make psychooncological referrals during the project
for at-risk patients?
50.00%
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0.00%
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I was able to make more referrals to
psycho-oncological services because of
the Distress Thermometer.
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I was able to identify more patients with
distress using the DT.
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40.00%

I thought the DT was an effective tool.
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How often did you screen patients for
psychosocial distress in the past 6
months?

I was able to reach out to social work
more because of the Distress
Thermometer.
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I will continue to use the Distress
Thermometer on my patients.

The Distress Thermometer does not
impede my workflow.

How easy was it to use the Distress
Thermometer?
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0.00%
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Appendix T: Patient Results

Count of Distress Thermometer Score
12
10
8
Count of
Distress
Thermometer
Score

6
4
2
0
0

1

2

3

4

5

6

7

8

Practical Problems
% of patients
Treatment decisions
17.9%
Insurance/financial
16.1%
Housing
8.9%
Work/school
7.1%
Transportation
5.4%
Child care
1.8%
Family Problems
% of patients
Dealing with children

8.9%

Family health issues

8.9%

Dealing with partner

5.4%

Ability to have children

1.8%
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Physical Problems
Percentage of patients

*

Fatigue
Sleep

51.8%

Emotional Problems

Tingling in hands/feet
Worry
Pain
Sadness
Appearance
Fears
Skin dry/itchy
Nervousness
Constipation
Depression
Eating
Loss of interest in usual activities
Getting around
Breathing

42.9%

% of patients
41.1%
26.8%
23.2%
21.4%
14.3%
10.7%

33.9%
28.6%
19.6%
19.6%
14.3%
12.5%
12.5%
10.7%

Memory/concentration

10.7%

Nausea

10.7%

Nose dry/congested

10.7%

Diarrhea

8.9%

Indigestion

8.9%

Sexual

8.9%

Changes in urination

7.1%

Bathing/Dressing

3.6%

Feeling swollen

3.6%

Fevers

3.6%

Mouth sores

1.8%

Substance abuse

1.8%

